MyFinsight
Home
Blog
About
Cash
$4,031,780
(-39.28%↓ Y/Y)
Advances on research and
development contract...
$208,972
(0.00%↑ Y/Y)
Prepaid insurance
$126,264
(-11.56%↓ Y/Y)
Prepaid financing costs
$52,666
Prepaid expenses
$10,000
(0.00%↑ Y/Y)
Interest receivable
$6,986
Total current assets
$4,436,668
(-36.64%↓ Y/Y)
Total assets
$4,436,668
(-36.64%↓ Y/Y)
Total liabilities and
stockholders equity
$4,436,668
(-36.64%↓ Y/Y)
Total stockholders
equity
$3,924,650
(-40.50%↓ Y/Y)
Total liabilities
$512,018
(26.07%↑ Y/Y)
Accumulated deficit
-$89,670,059
(-3.33%↓ Y/Y)
Additional paid-in capital
$93,592,899
(0.24%↑ Y/Y)
Total current
liabilities
$512,018
(26.07%↑ Y/Y)
Common stock, 0.001 par
value per share...
$1,810
(7.42%↑ Y/Y)
Accounts payable and
accrued expenses
$511,472
(26.69%↑ Y/Y)
Warrant liability
$546
(-77.37%↓ Y/Y)
Back
Back
Balance Sheet
Bone Biologics Corp (BBLGW)
Bone Biologics Corp (BBLGW)
source: myfinsight.com